Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (7479)	12/11/2002 11:34:49 AM
From: scaram(o)uche	Read Replies (2) of 52153

>> I have a small option bet on crxa getting approval. I find it very curious that all of a sudden the fda drops its objections 3 weeks in front of the panel. << Until that happened, I agreed with Peter..... I also thought that the drama would be sublime. Now? I believe that both parties will skirt the old Coulter issues. Looks like OGSI may have also found a work-around? Will sustained-release Risperdal be next? And what the heck just happened with FRX??!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next